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GENERAL INTRODUCTION 
Oxidative Stress 
Dioxygen (O^) serves as the eventual oxidant in aerobic respiration and is therefore 
essential for aerobic organisms. It also has been known for a long time that oxygen is toxic. It 
has been suggested that the oxygen toxicity is due to partially reduced oxygen species, such as 
the superoxide radical (O^*), hydrogen peroxide and the hydroxyl radical (OH ), 
generated through incomplete reduction of O^ or by the activity of various enzymes (1). The 
reactive oxygen species (ROS) have been shown to damage the cellular components, such as 
proteins, DNA, lipids, and carbohydrates (2). They are an inescapable consequence of aerobic 
life. 
The reactive oxygen species are also utilized in normal cellular processes. For example, 
fertilized sea urchin eggs produce H^O^ through the "respiratory burst of fertilization", and 
the produced H^O^ is used by ovoperoxidase to harden the egg envelope by cross-linking (3). 
During phagocytosis, macrophages produces large amounts of the reactive oxygen species. 
This phagocytosis-associated oxidative metabolism is important for microbicidal activity of 
macrophages (4). Activated neutrophils, eosinophils, and monocytes also release the reactive 
oxygen species as a defense against pathogens (S). It is an inescapable consequence that the 
ROS released by those cells cause damage to the neighboring cells. 
Since ROS are deleterious, cells have evolved mechanisms to scavenge the ROS and to 
repair damage (6). Various enzyme activities, including superoxide dismutase, catalase, 
glutathione peroxidase, and glutathione reductase, are important for eliminating the reactive 
oxygen species. Vitamin C and E, and glutathione can also neutralize ROS directly. It has 
been shown in our laboratory that protein S-thiolation (i.e., formation of mixed-disulfides 
between proteins and cellular glutathione) is a primary response to the reactive oxygen 
species. Moreover, the mixed disulfides produced during oxidative stress are transient and 
readily reversed by reduction reactions. Since protein S-thiolation results in activity changes 
of numerous enzymes (7, 8), metabolic changes due to protein S-thiokition should be 
considered as a primary result of oxidative stress. Since protein sulfhydryls are important for 
catalytic and structural integrity of numerous proteins, reversible protein S-thiolation and 
dethiolation may be an important cellular mechanism to protect the important protein thiols 
against oxidative stress. 
Protein S-thiolation 
Protein S-thiolation is the formation of protein mixed-disulfides with low molecular mass 
thiols. Although the low molecular mass thiols may be glutathione, cysteine, homocysteine, or 
others, most of the thiols found in protein mixed-disulfides in vivo has been identified as 
glutathione. Therefore, protein S-thiolation in vivo is mainly S-glutathiolatioa Protein S-
thiolation has been studied in various cells such as hepatocytes (9,10), heart cells (11,12), 
and human endothelial cells (13), utilizing various model oxidants such as /-butyl 
hydroperoxide, menadione, diquat, diamide, and hydrogen peroxide. Recently, stimulated 
murine macrophages and human neutrophils were also studied, in an effort to examine a 
biologically more relevant system for oxidative stress (14,15). These studies, with various 
cells and oxidants, showed that each cell type contained a unique set of S-thiolated proteins. 
Therefore, the effect of oxidative stress may also be unique for each cell type. 
Protein S-thiolation can occur by a thiol-disulfide exchange between protein thiols and low 
molecular mass disulfides such as glutathione disulfide in vitro. Many researchers consider 
that thiol-disulfide exchange reactions may be the major mechanism for the formation of S-
thiolated proteins because oxidative stress causes formation of glutathione disulfide (16). In 
many cases, the stimulation of protein S-thiolation accompanies an increase of glutathione 
disulfide. However, thiol-disulfide exchange is not the only mechanism for protein S-
thiolation. The following observations suggest a second mechanism of S-thiolation. First, the 
thiol-disulfide exchange reaction is relatively slow to explain the rapid S-thiolation in cells 
(17). To overcome this problem, it has been suggested that S-thiolation might be more rapid if 
catalyzed by an enzyme such as thioltransferase (18). However, not a single substrate protein 
for this reaction has been described. Second, the increase in glutathione disulfide is not a 
prerequisite for S-thiolation, and S-thiolation is observed even under the conditions in which a 
significant amount of glutathione disulfide is not formed (IS). Therefore, the formation of 
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glutathione disulfide should be considered as an unavoidable side reaction of oxidative stress, 
and a reaction which may not be directly tied to S-thiolation. 
Protein S-thiolation via oxyradical-initiated intermediates has been proposed to explain 
rapid S-thiolation (19, 20). This mechanism suggests that protein thiyl radicals and/or sulfenic 
acids are generated by ROS. Those "activated protein thiols", in turn, react with the reduced 
glutathione (GSH) directly to result in the formation of mixed disulfides. In this case, the 
formation of glutathione disulfide is not required for S-thiolation. A thiyl radical of 
hemoglobin was found in erythrocytes from rats fed with hydroperoxides (21), indicating that 
protein thiyl radicals were present in intact cells. 
Several S-thiolated proteins has been identified from various cells. In rat hepatocytes, the 
30 IcDa protein is the most extensively S-thiolated protein by /-butyl hydroperoxide and 
diamide. It was identified as carbonic anhydrase m (22). The most extensively S-thiolated in 
PMA (phorbol 12-myristate 13-acetate)-stimulated neutrophils, a 42 kDa protein, was 
identified as actin (15). Recently, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was 
identified as a major S-thiolated protein in human endothelial cells (23) and monocytes (24). 
Since each cell type contains a unique set of S-thiolated proteins, the effect of oxidative stress 
may also be unique for each cell type. Therefore, identification of the S-thiolated proteins in 
various cells may be an essential step in understanding the effect of oxidative stress. 
Unfortunately, the complexity of protein S-thiolation has not been appreciated, partly because 
few S-thiolated proteins have been identified. 
Carbonic anhydrase m (CA III) is the major carbonic anhydrase isozyme in the male rat 
liver and soleus muscle (2S). A crystal structure of bovine muscle CA ni has been solved at 
high resolution (26), and human muscle CA in has been cloned and well characterized (27). 
According to those studies, CA ni is the least active form of carbonic anhydrase, showing 
only 0.3 % of the activity of carbonic anhydrase n, the major isoform in erythrocjrtes. Rat 
liver CA m has been purified in our laboratory, and the enzymatic activity compared with 
carbonic anhydrases from other sources. Rat liver CA m showed unexpectedly high activity 
(100 times more active than bovine and human muscle CA ni), and the catalytic properties 
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were quite different from other CA Ill's. Recently, the partial amino acid sequence of rat liver 
carbonic anhydrase m was deduced from the nucleotide sequence of cloned cDNA. The 
amino acid sequence of rat liver CA in was almost identical to that of rat muscle CA m. One 
interesting feature of the partial sequence was that rat liver CAin contained the conserved 
phenylalanine residue that has been associated with the lower activity of bovine and human 
muscle CA III. With the human enzyme, the CA ni activity increased when the phenylalanine 
was replaced with smaller amino acids (28-30). A recent X-ray crystallography study showed 
that the active site structures of bovine muscle and rat liver CA m were superimposed on 
each other. Therefore, the structural basis for the lower activity of human and bovine muscle 
CA in, and for the higher activity of rat liver CA HI must be addressed. In order to determine 
the complete sequence of rat liver CA in, the cloning of the CA ni cDNA is currently under 
way. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been identified as a major S-
thiolated protein in hydrogen peroxide-treated monocytes, endothelial cells, and lung 
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carcinoma cells. When the cells containing S-labeled glutathione were treated with hydrogen 
peroxide, GAPDH was labeled with the radioactive glutathione and inactivation of the enzyme 
activity was directly correlated with the S-thiolation. Diamide, which caused S-thiolation of 
the same set of hepatocyte proteins as /-butyl hydroperoxide, did not S-thiolated human 
endothelial GAPDH (23). Since diamide caused extensive oxidation of cellular glutathione 
and the same concentration of diamide did not stimulate S-thiolation of GAPDH, thiol-
disulfide exchange could not be the mechanism of GAPDH S-thiolation. Oxyradical-initiated 
S-thiolation was suggested. Since pure GAPDH was also inactivated by hydrogen peroxide 
alone, intramolecular disulfide bond formation or sulfenic acid formation instead of S-
thiolation have been suggested as an inactivation mechanism. Overall, it will be very 
interesting to examine the structural basis of GAPDH inactivation by S-thiolation, including 
the competition between glutathione and a substrate, NADH, because the S-thiolation site 
overlaps with the NADH-binding site. 
Recently, it has been suggested that transcription factors such as Fos/Jun, NF-kB, and 
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OxyR are regulated by oxidation/reduction of sulfhydryk (31, 32). Oxidation of sulfhydryl(s) 
by hydrogen peroxide activates the transcription factor, OxyR, and the activation is reversed 
by a reducing agent, dithiothreitol. Storz et al. suggested that OxyR may be regulated by 
suifenic acid formation (32), but no experimental evidence was presented to support sulfenic 
acid formation. They reported that OxyR is regulated by oxidation/reduction even after 
changing S out of 6 cysteines to serines. Therefore, it is still possible that S-thiolation of the 
remaining sulfhydryl activates OxyR The suggestion that Fos/Jun and NF-kB are regulated by 
oxidation/reduction is based on the OxyR experiment, and the molecular nature of the 
oxidation/reduction has not been adequately addressed. 
It has been reported that many enzymes, such as glutamine synthetase, creatine kinase, 
glyceraldehyde-3-phosphate dehydrogenase, lactate dehydrogenase, and pyruvate kinase are 
inactivated by mixed-function oxidation systems (33). The oxidative inactivation accompanies 
the conversion of some amino acid side chains to carbonyl derivatives (34) and the carbonyls 
are accumulated in cells during ageing (35, 36). The inactivation ofE. coli glutamine 
synthetase also correlates with modification of a single histidine residue in each enzyme 
subunit and makes the enzyme susceptible to proteolytic degradation (37). 
Recently, it was shown in our lab that oxyradicals oxidized carbonic anhydrase HI 
irreversibly in the absence of glutathione. Protein S-thiolation occurred in the presence of 
glutathione (GSH) and the oxidation was reversed by reduction. Therefore, one possble 
function of protein S-thiolation may be the protection of functionally important protein 
sulfhydryls during oxidative stress through reversible S-thiolation/dethiolation of the 
potentially damaged sulfhydryls. 
Gilbert (16) and Ziegler (7) suggested that biological disulfides such as glutathione 
disulfide (GSSG) might serve as messengers in metabolic regulation and that reversible S-
thiolation/dethiolation of various enzymes may regulate metabolic pathways in cells. Although 
protein S-thiolation will certainly result in dramatic changes in cellular metabolism due to 
inactivation or activation of many enzymes, it is still controversial whether the intracellular 
redox state of cellular glutathione is significantly perturbed in response to normal 
6 
physiological signals. The inflammatory response of macrophages and neutrophils may be an 
example of this perturbation. Chai et al. (9, IS) showed that some protein in hepatocytes were 
significantly S-thiolated under the culture conditions, even without adding exogenous 
oxidants. Therefore, some proteins may be more susceptible to the changes in the GSH/GSSG 
redox potential and the regulation of those proteins may be very important. S-thiolation of 
carbonic anhydrase m and phosphorylase b did not change the enzyme activities, although 
glyceraldehyde-3-phosphate dehydrogenase and creatine kinase were inactivated by S-
thiolation. Therefore, not all the S-thiolation is "regulatory" and the function of protein S-
thiolation may be to scavenge oxyradicals in some cases. 
Dethiolation 
Dethiolation is the reduction of protein mixed-disulfides. As discussed above, this reaction 
has received attention for some time as a means of regulating enzyme activities. 
When hepatocytes and heart cells were exposed to Nbutyl hydroperoxide, S-thiolation of 
proteins was quite transient, that is, the maximum S-thiolation occurred within S min and the 
extent of S-thiolation decreased rapidly thereafter. Since approximately SO nmol/mg protein of 
total soluble protein thiols were estimated to be available for S-thiolation, the molar 
concentration of the thiols was approximately 10 mM in cells. S-thiolation in O.S mM /-butyl 
hydroperoxide-treated hepatocytes was less than S nmol/mg protein, less than 10 % of the 
total available protein thiols. Rapid dethiolation in these cells and the limited amount of S-
thiolation strongly suggested that the mechanisms for dethiolation are of major importance in 
the metabolism of S-thiolated proteins in intact cells. 
Dethiolation can occur non-enzymatically by thiol-disulfide exchange reaction between S-
thiolated proteins and reduced glutathione (GSH). This mechanism is supported by the fact 
that most cells contain high concentrations (1 to 10 mM) of glutathione. However, thiol-
disulfide exchange may not be the only important mechanism for dethiolation, because the 
thiol-disulfide exchange reaction alone is relatively slow to explain the rapid dethiolation in 
cells (22). 
Partially purified thioredoxin-like and glutaredoxin-like activities from various tissues, and 
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E. coli thioredoxin, greatly enhance the rate of dethiolation (38). The efifective dethiolation by 
E. coli thioredoxin, the thioredoxin-like and glutaredoxin-like activities, and relatively slow 
dethiolation by reduced glutathione (GSH) alone, suggest that "enzyme"-catalyzed 
dethiolation may be a major mechanism for dethiolation in cells. 
Thioredoxin 
Thioredoxin is a small protein with the molecular mass of 12 kDa originally isolated from 
E. coli as a hydrogen donor for ribonucleotide reduction (39). E. coli thioredoxin contains 
two cysteines at the active site with the conserved amino acid sequence, -Trp-Cys-Gly-Pro-
Cys- (40). The "spatially close" cysteine thiols undergo oxidation/reduction cycles during the 
reduction of ribonucleoside 5'-diphosphate to deoxyribonucleoside S'-diphosphate. The 
disulfide in the oxidized form of thioredoxin [Trx-S^] is reduced to a dithiol ITrx-(SH)2] by 
NADPH in a reaction catalyzed by thioredoxin reductase (41). The reduced form of thiore­
doxin [Trx-(SH)2] is then oxidized in a reaction by ribonucleotide reductase. 
In addition to deoxyribonucleotide synthesis, thioredoxin has been implicated in a wide 
variety of reactions, including methionine sulfoxide reduction and sulfate reduction (42-45). 
Trx-(SH)2 is also an essential subunit of phage T7 DNA polymerase in the virus-infected cells 
(46) and it is required for the assembly of filamentous phages (47). In vitro the dithiol form of 
thioredoxin has been knov^oi as a protein disulfide reductant. The protein disulfides reduced by 
thioredoxin include apocytochrome c, chymotrypsin, trypsin, insulin, proinsulin, fibrinogen, 
choriogonadotropin, and a-macroglobulin (48-51). The reduction of insulin and DTNB is 
often used in the assay of thioredoxin activity (39, 52, 53). 
Thioredoxin is a ubiquitous protein also found in yeast, plants, and animal cells. The genes 
encoding two different thioredoxins were cloned from yeast, Saccharomyces cerevisiae (54, 
55) and the thioredoxins showed about 80 % amino acid sequence identity. TRX2 gene, one 
of the yeast thioredoxin genes, was later identified essential for YAPl transcription factor-
dependent resistance to oxidative stress (56). Overall, the molecular nature and the cellular 
functions of yeast thioredoxins have not been extensively studied. Thioredoxins have been 
also studied in plants. A unique feature of the plant thioredoxin system is that plant 
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thioredoxin is reduced by ferredoxin-thioredoxin reductase instead of NADPH-thioredoxin 
reductase (57). It has been suggested that the plant thioredoxin system mediates 
photoactivation of various enzymes such as fructose 1,6-bisphosphatase, NADP-
glyceraldehyde 3-phosphate dehydrogenase, and NADP-malate dehydrogenase (58), and that 
thioredoxin is essential for photosynthetic growth (59). 
Thioredoxins have been characterized from various animal sources such as bovine liver 
(52), rat liver (60), rabbit bone marrow (61), and human lymphocytes (62). The amino acid 
sequence of thioredoxin from rabbit bone marrow was determined by tandem mass 
spectroscopy (63), and that of human lymphoid cells and chicken embryo fibroblasts were 
derived from cloned cDNA sequences (62, 64). The animal thioredoxins have the same active 
site sequence, -Trp-Cys-Gly-Pro-Cys-, as E. coli thioredoxin, and also contain 3 additional 
cysteines apart from the active site. Two of the cysteines, Cys 68 and Cys 72, form an 
68 72 
additional "vicinal" cysteine pair with the conserved sequence, - Cys-Glu-Val-Lys- Cys-. 
Those cysteines are apparently oxidized to disulfides during storage, resulting in aggregation 
and inactivation of the protein (65). The mutation of Cys 72 to serine prevented from both 
aggregation of human thioredoxin and inactivation by DTNB (66). The fiinctional importance 
of the Cys 72 has also been described by another report, which suggests that thioredoxin is in­
volved in the "early pregnancy factor (EPF)" system (67). The EPF system is assayed by a 
lymphocyte-modifying activity in pregnancy sera, that inhibits rosette formation. The mutation 
of cysteine 72 to serine completely eliminates the thioredoxin activity in the EPF assay, and 
mutation of the active site cysteines to serines does not have any effect (67). This indicates 
that the "extra cysteines" are also biologically important. 
The mammalian thioredoxins have a variety of activities. Thioredoxins from rat liver and 
calf thymus facilitate reduction of insulin disulfides (60, 68). It also has been suggested that 
thioredoxin serves as glucocorticoid receptor-activating factor (69). Recently, It has also been 
showed that overexpression of thioredoxin inhibits the transcription factor, NF-kB, and 
activates another transcription factor, AP-1 (70), implicating that thioredoxin may be involved 
in regulation of those transcription factors. 
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It has been shown that the adult T cell leukemia-derived factor (ADF) which induces 
interleukin 2 receptors on human B lymphocytes is thioredoxin (71). This suggests that 
thioredoxin acts as a interleukin 1 species (72) and as an autocrine growth factor (73). 
Thioredoxin may act as an interleukin species through the protein disufide reductase activity. 
Rubartelli et al. pointed out that thioredoxin is a protein secreted from fibroblasts, airway 
epithelial cells, and activated B and T cells without a signal sequence, similar to the secretion 
of interleukin IB (74). Rozell et al. showed that rat thioredoxin was localized in the cytoplasm 
of cells, and was enriched at secretory granules in both endocrine and exocrine cells (75). This 
localization of thioredoxin in cells may be related with the secretion of thioredoxin from those 
cells. Recently, induction of human thioredoxin in glial cells was reported after transient 
global ischemia, suggesting a role of thioredoxin in neuroprotection during ischemic injury 
(76). 
Although thioredoxin was first isolated as a hydrogen donor for ribonucleotide reductase, 
it had a variety of activities including reduction of protein disulfides, action as an interleukin 
species, and activation of glucocorticoid receptor. The list of the functions of this versatile 
protein is long and frirther investigation is required to reveal its cellular functions. 
Glutaredoxin 
Glutaredoxin is also a small protein (10 kDa) first isolated as a hydrogen donor for 
ribonucleotide reductase from a mutant of E coli lacking thioredoxin activity (77). E. coli 
glutaredoxin contains two cysteines at the active site with the amino acid sequence, -Cys-Pro-
Tyr-Cys- (78, 79), and the cysteines undergo oxidation/reduction cycle, similar to that of 
thioredoxin. Glutaredoxin is distinguished from thioredoxin is by the reduction of the oxidized 
form of glutaredoxin (Grx-S^) with glutathione (GSH) (80, 81). Glutaredoxin is less abundant 
in E. coli than thioredoxin, and it has a lower K for ribonucleotide reductase. Glutaredoxin is 
m 
also involved in the reduction of disulfides and sulfate (81, 82), but it is not able to substitute 
for thioredoxin in methionine sulfoxide reduction (83). A null mutation of E. coli, lacking 
both thioredoxin and glutaredoxin, suggests that thioredoxin and glutaredoxin may not be es­
sential for ribonucleotide reduction or for sulfate reduction, and that a new GSH-dependent 
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hydrogen donor for ribonucleotide reductase may exist in E. coli (84, 85). 
Glutaredoxin has also been called thioltransferase. This name was first introduced to 
describe an enzyme activity which enhances the reduction of homocysteine, glutathione-
coenzyme A mixed-disulfide, and cysteine-glutathione mixed-disulfide by glutathione (86). 
Mannervik and Axelsson introduced the term, suggesting that it catalyzed thiol-disulfide 
interchange (87). It was suggested that thioltransferase increased both the formation (S-
thiolation) and reduction (dethiolation) of protein mixed-disulfides (88). It should be pointed 
out that, as discussed above in protein S-thiolation, not a single substrate protein has been 
found to be S-thiolated by this enzymatic mechanism. 
Glutaredoxin has also been characterized from calf thymus (89), pig liver (90), rabbit bone 
marrow (91), and human erythrocytes (92). The mammalian glutaredoxins have disulfide 
reductase activities and the activity assay often uses the reduction of disulfides such as S-
sulfocysteine and hydroxyethyl disulfide (89). Gravina and Mieyal reported that glutaredoxin 
of from human red blood cells significantly enhanced the dethiolation rate of S-glutathiolated 
hemoglobin (93). 
Although the name "glutaredoxin" was suggested for a protein that acted as a hydrogen 
donor for ribonucleotide reductase, glutaredoxin from rabbit bone marrows was not active in 
the homologous ribonucleotide reductase assay in the presence of GSH, glutathione 
reductase, and NADPH (94). Pig liver glutaredoxin was also inactive in the rabbit andE. coli 
ribonucleotide reductase system, whereas calf thymus glutaredoxin was active (86, 9S). 
Therefore, the role of mammalian glutaredoxins in ribonucleotide reduction remains for 
further investigation. 
The mammalian glutaredoxins also contain an additional cysteine pair in the conserved 
sequence, -Cys-Ile-Gly-Gly-Cys-, although the function of those conserved cysteines is 
unclear. Unlike the variety of functions of thioredoxin, there have only a few reports of 
additional functions for glutaredoxin. The mammalian glutaredoxins show the 
dehydroascorbate reductase (96), and glutaredoxin-like protein in rat liver and kidney 
promotes iodothyronine S'-deiodinase activities (97). 
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Protein disulfide isomerase 
Protein disulfide isomerase (PDI) is an abundant protein present in the lumen of the 
endoplasmic reticulum (98). It is a homodimeric protein with a subunit molecular mass of 57 
kDa. PDI has been so named because it catalyzes disulfide formation in secretory proteins and 
isomerization of intramolecular disulfide bonds. PDI has two distinct but identical regions 
similar to the active site of thioredoxin, containing the conserved amino acid sequence, -Cys-
His-Gly-Cys- (99). Therefore, PDI is a member of the protein &mily which have two 
"spatially close" cysteines at the active site. 
Protein disulfide isomerase was first isolated from rat liver microsomes as an enzyme 
catalyzing the conversion of inactive, reduced bovine pancreatic ribonuclease to the active 
form (100). It was shown later that the same enzyme preparation also activated randomly 
oxidized ("scrambled") ribonuclease (101). 
Protein disulfide isomerase (PDI) is a multifunctional protein. It serves as the 6-subunit of 
prolyl hydroxylase which catalyzes hydroxylation of proline residues within a-chains of 
procollagen (102,103). It has been shown that PDI has dehydroascorbate reductase activity 
(96). Since ascorbic acid is a cofactor in the prolyl hydroxylase reaction, PDI may function to 
regenerate ascorbic acid. 
An enzyme which reacted with antibodies against guinea pig uterus phosphoinositide-
specific phospholipase C (PI-PLC) was cloned from a rat cDNA library (104). The derived 
amino acid sequence showed that it was not the same as rat liver PDI, but it had two separate 
regions containing a cysteine pair with the sequence, -Cys-Gly-His-Cys-. It is not clear at this 
point whether the cloned protein has the PDI activity, and what the function of the PI-PLC 
isoenzjone is. 
Other proteins 
The sequence (-Cys-X-X-Cys-) common to the redox active dithiols in thioredoxin, 
glutaredoxin, and protein disulfide isomerase has been found in many other proteins such as 
the 6-subunit of ovine follitropin and bovine lutropin (105), and DsbA (106). DsbA is a 
periplasmic protein in E. coli with a molecular mass of 21 kDa. It has been suggested that the 
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function of DsbA is a bacterial protein disulfide isomerase, and that it is involved in the 
formation of protein disulfides. Bateriophage T4 also contains a unique protein which 
contains both thioredoxin and glutaredoxin properties, with the active site sequence -Cys-Val-
Tyr-Cys- (107). That is, it can be reduced by either thioredoxin reductase and NADPH or 
GSH alone (108). 
Although the number of proteins containing "spatially vicinal" dithiols is increasing and 
they often show the disulfide reducing activity, they have generally been considered as 
nonspecific reductants. The specificity with protein disulfides have been little studied. In the 
first part of this dissertation, the relative specificities of glutaredoxin, thioredoxin, and protein 
disulfide isomerase for dethiolation of protein mixed-disulfides are compared. Glutaredoxin is 
the most effective among those tested. The structural basis of the dethiolation by glutaredoxin 
is discussed. The second part of this dissertation will present evidence for noncovalent 
glutathione-binding to S-thiolated proteins during dethiolation. The implication of 
glutathione-binding to protein will also be discussed. 
Dissertation Organization 
This dissertation contains two papers that will be submitted for publication with minor 
modifications to meet the journal's requirements. Following the papers, a general conclusion 
of this dissertatation is presented. References cited in the general introduction follow the 
general conclusion. 
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DETfflOLATION OF ^^S-GLUTATfflOLATED HEPATOCYTE PROTEINS BY 
GLUTAREDOXIN, TfflOREDOXIN. AND PROTEIN DISULFIDE ISOMERASE 
A paper to be submitted to the Journal of Biological Chemistry 
Che-Hun Jung and James A. Thomas 
ABSTRACT 
The activity of glutaredoxin, thioredoxin, protein disulfide isomerase as dethiolases (i.e., 
enzymes catalyzing reduction of protein mixed-disulfides) was studied utilizing a mixture of 
35 35 hepatocyte S-glutathiolated proteins. The S-glutathiolated protein mixture was prepared 
35 from S-labeled rat hepatocytes, by stimulating S-glutathiolation with diamide. Dethiolation 
35 (i.e., reduction of protein mixed-disulfides) of individual S-labeled protein bands was 
analyzed by combining SDS-PAGE and autoradiography. This mixture had no contaminating 
glutaredoxin- or thioredoxin-like activity and it was suitable for studying the effects of the 
proteins as dethiolating agents. 
All of the protein bands without exception could be completely dethiolated by pure 
glutaredoxin, thioredoxin, or protein disulfide isomerase. Glutaredoxin was the most effective 
of the dethiolases. For example, the 30 IcDa protein, which has been identified as carbonic 
anhydrase m, was dethiolated 300 times fester by glutaredoxin than thioredoxin, and 200 
times fester than protein disulfide isomerase. Dethiolation rates of individual hepatocyte 
proteins varied in minor ways from protein to protein. For example, the IS, 30, and 48 kDa 
proteins were quickly dethiolated by glutaredoxin, and the 27,28, and 77 kDa proteins were 
dethiolated more slowly. The specificities of glutaredoxins from pig liver and bovine heart 
were compared, and were similar to each other. Thioredoxin from human and E. coli also 
have a similar reactivity and specificity. 
Insulin reduction by glutaredoxin, thioredoxin, and protein disulfide isomerase was also 
compared. On the contrary to protein disulfide isomerase and thioredoxin, glutaredoxin did 
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not facilitate insulin reduction, suggesting that glutaredoxin might be specific for S-
glutathiolated proteins. Protein disulfide isomerase was more effective than thioredoxin for 
insulin reduction. The standard redox potential of pig liver glutaredoxin was found to be 
- 0.159 ± 0.004 V, indicating that glutaredoxin was thermodjmamically a weaker reductant 
than E. coli thioredoxin (redox potential of - 0.260 V). The experiments described in this 
report strongly suggest that glutaredoxin is the major dethiolase for S-glutathiolated proteins 
in cells. Glutathione-binding at the active site of glutaredoxin is suggested as a structural 
factor for the effective dethiolation. 
INTRODUCTION 
An increase in the S-thiolation state of many proteins occurs rapidly in cells under 
oxidative stress (1-6). Since the dethiolation process counteracts this increase, it is important 
to understand its mechanism and the proteins responsible for dethiolation. All of the S-
thiolated proteins in hepatocytes and heart cells were quickly dethiolated in intact cells and the 
dethiolation rates were somewhat different from protein to protein (1, 5, 7). For example, a 
30 kDa protein band was readily dethiolated while a 45 kDa protein band remained S-
thiolated in ^butyl hydroperoxide-trated hepatocytes (7). 
Enzyme-catalyzed dethiolation has been studied (8-11), and partially purified thioredoxin 
and glutaredoxin from cardiac tissue and pure E. coli thioredoxin &cilitated the reduction of 
protein mixed-disulfides (8-11), 
Thioredoxin, originally thought to function as a hydrogen donor for ribonucleotide 
reduction, has also been known to cleave protein disulfide bonds (12-15). In fact, the assay of 
thioredoxin activity often utilizes the reduction of insulin (16,17). Glutaredoxin, also known 
as thioltransferase, has been reported to reduce protein disulfides (18), and commonly used 
activity assays are based on the reduction of various disulfides such as S-sulfocysteine and 
hydroxyethyl disulfide (19-21). Protein disulfide isomerase, a major protein in the endoplasmic 
reticulum, can also facilitate the reduction of insulin disulfide (22,23), and many other 
proteins (24). These three proteins have an active site composed of "spatially vicinal" dithiols 
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separated by two amino acids. The dithiol proteins have been considered to be nonspecific 
reductants and their activities have not been compared in direct experiments involving specific 
reactions. 
In this report, we compared the relative reactivities of glutaredoxin, thioredoxin, and 
protein disulfide isomerase as dethiolases of protein mixed-disulfides. The dethiolation rates 
of the mixture and of individual proteins were studied. Dethiolation rates differed somewhat 
from protein to protein and glutaredoxin was clearly the most effective on a molar basis 
among those tested. 
MATERIALS AND METHODS 
Human recombinant thioredoxin was a generous gift from Dr. Angela M. Gronenbom at 
National Institute of Diabetes and Digestive and Kidney Diseases, NIH, and pig liver 
glutaredoxin was from Dr. Wells at Michigan State University. E. coli thioredoxin was 
purchased from Calbiochem (La JoUa, CA). Glutathione, glutathione disulfide, dithiothreitol, 
bovine serum albumin, collagen, N-ethylmaleimide, galactose, and dexamethasone were from 
Sigma chemical Co. (St. Louis, MO). Insulin (bovine), transferrin (human), penicillin G, 
streptomycin sulfate, Leibovitz's L-15 medium with L-glutamine were from Gibco BRL 
(Grand Island, NY). CoUagenase was from Worthington biochemical Corp. (Freehold, NJ). 
SDS-PAGE molecular mass standards were from Bio-Rad laboratories (Richmond, CA). 
Tran^^S-label was from ICN biochemical. Inc. (Irvine, CA). Precasted 5-20 % gradient SDS-
PAGE gels were purchased from Jule Inc. (New Haven, CT). 
35 Preparation of S-gl;itathiolated Hepatocyte Proteins 
Sprague-Dawley male rats (200-250 g) (Sasco Co., Omaha, NE) were used to prepare 
hepatocytes by coUagenase digestion, as described by Bonney et al. (25). Cell viability was 
greater than 90% by trypan blue exclusion. The isolated hepatocytes were diluted to 0.5x10^ 
cells/ml in Leibovitz's L-15 medium, pH 7.6, supplemented with 18 mM Hepes, 0.2% bovine 
serum albumin, 5 ^g/ml insulin/transferrin, 1 ^M dexamethasone, 5 mg/ml galactose, 50 
Units/ml penicillin G, and 50 ^g/ml streptomycin sulfate and plated on collagen-coated dishes. 
16 
The hepatocytes were incubated at 37 "C for 48 hours before [^^S]-labeling. 
Cells were incubated in L-IS medium containing IS ^g/ml cycloheximide for 30 minutes 
• 35 prior to labeling. Cycloheximide prevented protein synthesis during S-labeling. 
Cycloheximide-treated cells were then incubated for 4 hours with serum-free CMRL-1415 
medium containing 40 ^M methionine, 10 ^M cystine, and IS ^g/ml cycloheximide with 
3x10 dpm/^mole. The low concentration of methionine and cystine in CMRL-141 S medium 
was convenient for labeling the cells with a higher specific activity. The specific activity of 
glutathione in cells was analyzed by HPLC as described by Fariss and Reed (26) and modified 
35 by Chai et al. (S). The acid-soluble materials in S-labeled hepatocytes were separated by a 
HPLC column and fractions were counted by liquid scintillation counter. 
35 S-labeled hepatocytes were treated with 2 mM diamide for S minutes to S-thiolate 
proteins. After incubation, the medium was removed and cells were rinsed twice with cold 
phosphate buffered saline. Cells were lysed and soluble proteins were extracted within a 
minute by scraping cells in 20 mM Hepes pH 7.4 buffer containing 5 mM EDTA, S mM 
EGTA, and SO mM N-ethylmaleimide. N-ethylmaleimide reacted with all reactive free 
sulfhydryls in the extract. The extract was centrifuged at 10,000 x g for 30 minutes to obtain a 
particulate-free cell extract. The supernatant was dialyzed to remove low molecular mass 
radioactivity using 12 kDa molecular mass cut-off dialysis tubing. Glutaredoxin and 
thioredoxin activity in the extract were measured as described by Thomas et al. (27), neither 
glutaredoxin nor thioredoxin activity was detected in the extract. 
Assay of dethiolation 
Glutaredoxin and protein disulfide isomerase assay Pig liver glutaredoxin, bovine heart 
glutaredoxin, and bovine liver protein disulfide isomerase were preincubated at 30 °C with 
glutathione in 20 mM 6-glycerophosphate buffer, pH 7. The dethiolation reactions were 
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started by adding the S-thiolated hepatocyte proteins (final concentration, 1 mg/ml). The 
final concentration of glutathione was 0.3 mM. After an appropriate incubation time, proteins 
were precipitated by adding ice-cold bovine serum albumin (final concentration, 6 mg/ml) and 
trichloroacetic acid (fmal concentration, 10 %) in turn. The TCA-soluble radioactivity in the 
17 
supernatant after centrifugation, released by dethiolation, was counted by liquid scintillation. 
Thioredoxin assay Human and E. coli thioredoxin were preincubated at 30 °C with 
NADPH and purified bovine heart thioredoxin reductase (see the next section) in 20 mM 6-
glycerophosphate buffer, pH 7. The final concentration of NADPH was 0.4 mM and that of 
thioredoxin reductase was 0.3 mg/ml. The extent of dethiolation was measured as described 
above for glutaredoxin and protein disulfide isomerase. 
Gel analysis of the dethiolation of individual protein bands Dethiolation of individual 
protein bands was assessed by combining SDS-PAGE and autoradiography. Reactions were 
stopped by adding an equal volume of 0.12S M Tris-Cl buffer, pH 6.8 containing 4 % sodium 
dodecyl sul&te, 20 % glycerol, 0.008 % bromophenol blue, and 80 mM N-ethylmaleimide. N-
ethylmaleimide stopped the reaction and blocked free sulfhydryls. Proteins were separated by 
5-20 % gradient SDS-PAGE and the radioactivity associated with individual bands was 
quantitated by autoradiography and densitometry. 
Purification of Thioredoxin Reductase from Bovine Heart 
Thioredoxin reductase activity was measured during purification by a coupled reaction in 
which thioredoxin reductase reduces E. coli thioredoxin and the reduced thioredoxin in turn 
reduces the mixed-disulGde of S-[^H]glutathiolated phosphorylase b (27). The mixture of 0.5 
mM NADPH, 2 jiM E. coli thioredoxin, 6 mg/ml bovine serum albumin, and 0.3 ^iM S-[^H] 
glutathiolated phosphorylase b in 20 mM B-glycerophosphate buffer, pH 7, was incubated 
with a fraction containing thioredoxin reductase at 30 °C for 10 min. The protein-associated 
radioactivity was then precipitated by 10 % trichloroacetic acid (TCA) and TCA-soluble 
radioactivity in the supernatant was determined. One unit of thioredoxin activity corresponded 
to the release of 1 ^mol of [ H]GSH/min. The thioredoxin reductase activity was linearly 
proportional up to 2 ^units of thioredoxin reductase, under the assay condition. 
Thioredoxin reductase was purified from bovine heart as described by Luthman and 
Holmgren (17) with slight modifications. Heart tissue was homogenized in a Waring Blender 
with 3 volumes of 20 mM Tris-Cl buffer, pH 7.4. The homogenate was centrifuged at 100,000 
X g for 1 hour at 4 °C. The supernatant was filtered through glass wool, and then applied to a 
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DEAE-Trisacryl column pre-equiiibrated with 20 mM Tris-Cl buffer, pH 7.4. Thioredoxin 
reductase was eluted with 0-0.3 M NaCl gradient in the same buffer, and the active fractions 
were combined and concentrated in an Amicon concentrator with a YM 10 membrane. The 
concentrated fraction was applied to a Sephadex G-ISO column pre-equilibrated with 20 mM 
B-glycerophosphate buffer, pH 7.0, and the active fractions were concentrated in a Amicon 
concentrator. The concentrated fractions were applied to a Cibacron Blue agarose column 
pre-equilibrated with 20 mM Tris-Cl buffer, pH 8.0. Thioredoxin reductase was eluted with 0-
1 M KCl gradient. The purified thioredoxin reductase migrated as a single major band on 
SDS-PAGE with a molecular mass of 35 kDa. It has been reported that thioredoxin reductase 
from E. coli and other prokaryotes is a dimeric protein with the subunit molecular mass of 35 
kDa (28, 29). It has been reported that thioredoxin reductase from human liver (30), bovine 
liver (31), and cultured HeLa cells (32) have a subunit molecular mass of 58 kDa. Therefore, 
the molecular mass (35 kDa) of purified thioredoxin reductase suggests that bovine heart 
thioredoxin reductase is more similar to prokaryotic isoenzymes. The specific activity of the 
purified thioredoxin reductase was 0.3 mU/mg protein. The protein concentration was 
determined, as described by Lowry et al. (33), using bovine serum albumin as standard. 
Purification of Bovine Heart GiutaredoMn 
Glutaredoxin activity was determined during purification, as described by Thomas et al. 
(27). The mixture of 0.3 mM glutathione, 6 mg/ml bovine serum albumin, and 0.3 ^iM S-
[ H]glutathiolated phosphorylase b in 20 mM B-glycerophosphate buffer, pH 7, was incubated 
with a fraction containing glutaredoxin at 30 °C for 5 min. Ten percent trichloroacetic acid 
(TCA) was added to precipitate protein-?issociated radioactivity and TCA-soluble 
radioactivity was determined. One unit of the glutaredoxin activity corresponded to the 
release of 1 ^mol of [ H]GSH/min under these assay condition. 
Bovine heart was homogenized in a Waring Blender with 5 volumes of 50 mM Tris-Cl 
buffer, pH 7.8 containing 5 mM EDTA and 0.2 mM PMSF. The homogenate was centrifliged 
at 10,000 X g for 1 hour at 4 °C, and the supernatant was filtered through glass wool. The 
filtered supernatant was precipitated with 70 % ammonium sulfate, and the pellet was 
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resuspended in a minimal volume of 20 mM sodium phosphate buffer, pH 7.0, and dialyzed 
overnight against the same buffer using dialysis tubing with 3500 molecular mass cutoff. Aiter 
centrifiigation to remove any insoluble material, the supernatant was applied to a Sephadex 
G-7S column pre-equilibrated with 20 mM sodium phosphate buffer, pH 7.0 containing 100 
dithiothreitol. The active fractions were combined and concentrated in a Amicon 
concentrator. The pH of the pooled fraction was adjusted to S.l by adding 1 M acetic acid 
dropwise, and it was applied to a CM-Sepharose column pre- equilibrated with 10 mM 
sodium acetate buffer, pH S. 1. Glutaredoxin was then eluted with a 0-0.1 M NaCl gradient in 
the same buffer. The active fractions were combined and concentrated in an Amicon 
concentrator with a YM 3 membrane. The concentrated fraction was focused for 4 hours in a 
Rotofor preparative isoelectric focusing chamber containing 2 % Ampholine, pH range 5 to 8. 
The active fractions were concentrated in a Amicon concentator with YM 3 membrane, and 
dialyzed to remove Ampholines. The specific activity of the purified glutaredoxin was 28 
mU/mg protein. The specific activity of pig liver recombinant glutaredoxin was 75 mU/mg 
protein. Therefore, pig liver glutaredoxin showed about 3 times higher activity than bovine 
heart glutaredoxin. 
RESULTS 
35 S-thiolated hepatocyte proteins 
S-thiolation of the same group hepatocyte protein bands is stimulated by either t-butyl 
hydroperoxide or menadione (5). Since diamide could produce more extensive S-thiolation of 
hepatocyte proteins, we first compared the proteins that were S-thiolated by diamide to those 
in menadione-treated cells. Figure 1 (A) shows this comparison. Both lanes show an identical 
pattern of ridioactivity suggesting that the same set of proteins might be S-thiolated with both 
agents and the modification by diamide was about 2 times greater than by menadione. 
The proteins S-thiolated in diamide-treated hepatocytes were examined by SDS-PAGE 
[Figure 1 (B)] and the relative amount of radioactivity on each protein band was determined 
by densitometry [Figure 1 (C)]. The 30 kDa protein, which has been identified as carbonic 
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anhydrase m (6), was the most abundant S-thiolated protein, containing 20 % of total 
radioactivity. Approximately 30 percent of the readily S-thiolated sites in hepatocyte proteins. 
All the protein bands were dethiolated by dithiothreitol, indicating that the radioactivity on 
proteins were incorporated by S-thiolation not by protein synthesis. The protein mixture 
contained less than 0.2 % TCA-soluble radioactivity before reduction with dithiothreitol. 
Identification of low molecular mass thiols bound to the S-thiolated proteins 
35 35 The S-labeled thiols in the hepatocytes used to prepare S-thiolated proteins were 
analyzed by ion-exchange HPLC chromatography, as described by Chai et al (5). Figure 2 (A) 
showed that about 80 % of the trichloroacetic acid-soluble radioactivity in the cells had the 
same retention time as glutathione. 
The radioactivity was released by dithiothreitol from the isolated, S-thiolated proteins and 
identified by the same HPLC method. About 84 % of protein-bound radioactivity was 
identified as glutathione, as shown in Figure 2 (B). Therefore, the mixed hepatocyte proteins 
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contamed primarily [ S]-glutathione (i.e., S-glutathiolated). Using the specific activity of the 
cellular glutathione pool, we calculated that fourteen nmoles of glutathione were bound to 1 
mg hepatocyte proteins. This represents approximately 30 percent of the readily S-thiolated 
sites in hepatocyte proteins. 
Dethiolation of mixed hepatocyte proteins 
Since glutaredoxin, thioredoxin, and protein disulfide isomerase (PDI) have been reported 
to facilitate protein disulfide reduction, they potentially catalyze reduction of protein mixed-
disulfides (i.e., dethiolation). In order to compare the effectiveness of glutaredoxin, 
35 thioredoxin, and protein disulfide isomerase in dethiolation of the mixed S-glutathiolated 
hepatocyte proteins, various concentrations of each dethiolating protein were incubated with 
the hepatocyte proteins for 5 minutes. Dethiolation occurred linearly up to 40 % dethiolation. 
As shown in Figure 3, each protein could catalyze the dethiolation of hepatocyte proteins. 
Glutaredoxin was &r more effective than PDI and thioredoxin on a molar basis. Incubation of 
the mixed proteins alone without any reducing agent did not affect the protein-bound 
radioactivity. Therefore, the loss of the radioactivity by the reducing agents was indeed due to 
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reduction of protein mixed-disulfides. Five % of radioactivity was released by 0.3 mM 
glutathione alone. In the absence of thioredoxin there was no dethiolation of the proteins by 
NADPH and thioredoxin reductase. With 0.4 nM of each protein, 40 % of protein-bound 
radioactivity was released by glutaredoxin, and less than 10 % by PDI. Therefore, 0.4 of 
glutaredoxin enhanced the effectiveness of glutathione 8 times. Both human and E. coli 
thioredoxin dethiolated 3 % of total radioactivity. 
Specificity of glutaredoxin, thioredoMn, and protein disulfide isomerase in dethiolation 
of hepatocyte proteins 
Miller and Thomas reported that the dethiolation rate of phosphorylase b by glutaredoxin 
were l.S times faster than that of carbonic anhydrase ni. (11). We speculated that 
glutaredoxin, thioredoxin, and protein disulfide isomerase might have unique substrate 
specificities. In other words, some proteins might be specifically dethiolated by glutaredoxin, 
and others by thioredoxin or protein disulfide isomerase. In order to examine the specificities 
for the mixture of hepatocyte proteins, the total mixture was dethiolated by 30 % with each 
dethiolating protein, and individual protein bands were assessed by autoradiography and 
densitometry. 
Figure 4 shows the extent of dethiolation of 11 repesentative hepatocyte proteins when the 
amount of each dethiolating protein is adjusted to give 30 % dethiolation in 5 min. On a molar 
basis, glutaredoxin was always more effective than any other dethiolating protein, because less 
glutaredoxin than any other protein was used for this experiment (see the legend of Figure 4). 
For example, glutaredoxin, thioredoxin, and protein disulfide isomerase dethiolated the 100 
kDa protein to a similar extent, but since 25 times less glutaredoxin was used, it dethiolated 
the 100 IcDa protein 25 times more effectively than thioredoxin. It was 60 times more 
effective than protein disulfide isomerase. Table 1 compares the effectiveness of thioredoxin 
and protein disulfide isomerase to that of glutaredoxin for 11 selected protein bands. 
Glutaredoxin dethiolated the 30 kDa protein (carbonic anhydrase III) 300 times more 
effectively than thioredoxin, and 200 times more efficiently than protein disulfide isomerase. 
It was possible to study the reduction state of thioredoxin under the reaction conditions 
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used in this experiment by isoelectric focusing. Figure S shows that most thioredoxin is in the 
reduced state under the reaction conditions, indicating that thioredoxin was sufficiently 
reduced during the course of reaction. Therefore, thioredoxin is intrinsically less active than 
glutaredoxin as a dethiolase. The concentration of glutaredoxin in hepatocytes is about 6 
(20, 36) and the concentration of thioredoxin in the liver has been reported to be 5-10 
(37). At those concentrations, glutaredoxin probably accounts for most of the dethiolation in 
these cells. Protein disulfide isomerase is approximately 10 |iM (38) and it is also localized to 
the endoplasmic reticulum. Therefore, the contributions of thioredoxin and protein disulfide 
isomerase to dethiolation may not be significant under physiological conditions. 
Specificity comparison of glutaredoiin and thioredoiin from difTerent sources 
Figure 6 (A) compares two different mammalian glutaredoxin firom pig liver and bovine 
heart. The data show no obvious difference between the two proteins. Human recombinant 
thioredoxin and E. coli thioredoxin were also compared, as shown in Figure 6 (B). The 
thioredoxins were also very similar to each other. 
Insulin reduction by glutaredoxin, thioredoxin, and protein disulfide isomerase 
In order to examine the specificity of the proteins for a different reaction, each protein was 
tested as a reductant of the disulfide bonds of insulin. Insulin reduction has been used to 
determine the activities of both thioredoxin and protein disulfide isomerase (17, 22). As 
shown in Figure 7, glutaredoxin was a poor reductant for insulin disulfides, while both 
thioredoxin and protein disulfide isomerase were quite efiGcient. Protein disulfide isomerase 
was the most effective. On a molar basis, protein disulfide isomerase was 10 times more 
effective than E. co// thioredoxin, and human and E. coli thioredoxins had a similar activity. 
Redox potential of pig liver glutaredoxin 
Gan and Wells reported that reduced pig liver glutaredoxin focused at a pi of 6.4 and it 
can be converted to a form with a pi of 8.0 by oxidation with 2-hydroxyethyl disulfide (36). In 
this paper, the redox state of pig liver glutaredoxin was assessed by isoelectric focusing by 
using this pi shift. As shown in Figure 8 (A), pig liver glutaredoxin, oxidized during storage. 
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was incubated in various mixture of GSH/GSSGfor 24 hrs at 25 "C and the free sulfhydryls 
were blocked with iodoacetic acid (lAA) to stop the reaction. The reduced form of pig liver 
glutaredoxin focused as one major and one minor band with pi's of 5.6 and S.S, respectively. 
The major one was used to calculate the amount of the reduced of glutaredoxin in our 
experiment. Unfortunately, the oxidized forms of the protein after iodoacetic acid reaction did 
not focus distinctly and could not be quantitated by densitometry. Therefore, changes in the 
amount of the reduced glutaredoxin were used to assess the redox state of glutaredoxin. 
The fraction of glutaredoxin in the reduced state (R) can be calculated from equation 2, 
when is the equilibrium constant for reaction 1. 
GRX +2GSH GRX_^ + GSSG (reaction!) 
ox red ^ ' 
= [GRX^ J[GSSG]/{[GRXJ[GSH]^} (equation!) 
R={[GSH]^/[GSSG]}/{K + [GSH]^/[GSSG]} (equation 2) 
eq 
Figure 8 (B) shows the relationship between [GSH]^/[GSSG] and the fraction of 
glutaredoxin in the reduced state (R). The solid line fits the equilibrium constant of K = 
J 1020 (Nf ). The equilibrium constant for each concentration of GSH and GSSG gave an 
average redox potential of - 0.159 ± 0.004 V. A redox potential of -0.248 V was used for the 
GSH/GSSG couple in this calculation (44, 45). That is, 
E° =E° - 0.02958 X logK 
GRX GSH/GSSG  ^'"6 '^ eq 
= -0.248 + 0.02958 X log(1020) = -0.159 (V) 
DISCUSSION 
When hepatocytes and heart cells were exposed to t-butyl hydroperoxide, S-thiolation of 
proteins was quite transient, that is, the maximal S-thiolation occurred within 5 min and the S-
thiolation was rapidly reversed thereafter. This transient S-thiolation can be explained by rapid 
metabolism of the hydroperoxide (39) and by rapid dethiolation of the S-thiolated proteins. 
The rapid dethiolation suggests that there must be a mechanism which actively dethiolates the 
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S-thioIated proteins and therefore maintains protein thiols as the reduced state in cells. 
Enzyme-catalyzed dethiolation has been suggested as a mechanism to explain the rapid 
dethiolation in hepatocytes, because of the relatively slow dethiolation by glutathione alone. 
Glutaredoxin, thioredoxin, and protein disulfide isomerase share a dithiol separated by two 
amino acids in their active sites. They have been suggested as reductants for protein disulfides 
but there has been no systematic comparison of the effectiveness of each protein in the 
reduction. In this report, we show that glutaredoxin is the most effective in dethiolation of 
hepatocyte proteins on a molar basis. 
The interaction between glutathione and the amino acids at the active site of glutaredoxin 
has been described from X-ray crystallography of S-glutathiolated glutaredoxin (41). The 
results strongly suggest that glutaredoxin has a glutathione-binding site near the active thiol 
pair. Thus, glutathione on S-glutathiolated proteins may abo bind to this site resulting in the 
facilitated dethiolation. Gravina and Mieyal reported that glutaredoxin did not fecilitate 
dethiolation of S-cysteinylated hemoglobin but that of S-glutathiolated hemoglobin (18). 
Yoshitake et al. abo reported that bovine liver glutaredoxin reactivated GSSG-inactivated 
phosphofructokinase more efficiently than bovine liver thioredoxin (42). The specific 
enhancement of dethiolation only for S-glutathiolated hemoglobin and the more efiRcient 
activation for GSSG-inactivated phosphofhictokinase may also be due to the glutathione-
binding at the active site of glutaredoxin. 
The redox potential of E. coli thioredoxin has been reported as - 0.26 V at pH 7 and 25 °C 
by Moore et al. (40) and by Krause et al. (23). The redox potential of pig liver glutaredoxin b 
determined as - 0.16 V in thb report. Thb high redox potential of glutaredoxin clearly 
indicates that E. coli thioredoxin b much stronger reductant than glutaredoxin 
thermodynamically, and that the more effective dethiolation by glutaredoxin than thioredoxin 
b not determined thermodynamically, but kinetically. 
The standard redox potential of glutaredoxin implies that glutaredoxin may be in the fully 
reduced state in the liver under the the reported concentrations of GSH and GSSG (10 mM 
GSH, GSH/GSSG = 300). Chai et al. reported that S-thiolation by /-butyl hydroperoxide was 
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transient (5), suggesting that there would be an efficient dethiolating activities. Under these 
conditions, about 80 % of glutathione became GSSG in 3 min, decreasing to 30 % in 30 min. 
With 2 mM GSH and 4 mM GSSG (80 % of the total GSH as GSSG), using the redox 
potential of - 0.16 V as determined in our work one can calculate that about 50 % of 
glutaredoxin would be in the reduced state. This implies that glutaredoxin can be quite active 
when the glutathione pool is highly oxidized. Menadione caused a gradual increase in protein 
S-thiolation with no apparent net dethiolation for up to 30 minutes. Approximately 97 % of 
glutathione was oxidized in 15 min and the redox state of glutathione remained up to 30 min. 
With 0.3 mM GSH and 4.85 mM GSSG (assuming that 97 % of the total GSH is oxidized), 
only 2 % of glutaredoxin would be in the reduced state. Therefore, S-thiolation by menadione 
may continually increase because glutaredoxin may not be significantly reduced. 
The redox potentials of other dethiol proteins such as DsbA and protein disulfide 
isomerase (PDI) has been reported. The standard redox potential of DsbA was reported as 
- 0.089 V using a reference redox potential, - 0.205 V, for GSSG/GSH system at pH 7 at 
30 °C, by Wunderlich and Glockhuber (43). This potential can be corrected to - 0.139 V by 
the suggested standard redox potential for GSSG/GSH, - 0.248 V, when that of 
NADP^/NADPH is - 0.310 V at pH 7.0 at 25 "C (44, 45). The redox potentials for bovine 
liver protein disulfide isomerase were also determined, but there was a significant 
disagreement between papers. Hawkins et al. reported the redox potential of bovine liver PDI 
as - 0.11 V (46). Lundstrom and Holmgren reported the redox potential of calf liver PDI as 
- 0.190 ± 0.010 V and - 0.175 ± 0.015 V, depending on the reference used in the 
determination (47). It has been suggested that the endoplasmic reticulum is an oxidizing 
environment (48). PDI and DsbA acts as oxidants in the oxidizing condition. The redox 
potential determination described in this paper is the first one for glutaredoxin from any 
sources. The high redox potential of glutaredoxin suggests that glutaredoxin itself can act as 
an oxidant depending on the redox condition in which it is present. Therfore, it will be very 
interesting to examine whether glutaredoxin is present in the cellular organelles other than the 
cytosol and whether it catalyzes disulfide bond formation. 
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It was an unexpected result that glutaredoxin was the most effective dethiolating protein 
among the dithiol proteins tested. This systematic comparison may be possible because a 
mixture of substrate was used. The method used in this report can be adapted in various 
protein modifications such as phosphorylation/dephosphorylation and sul&tion/desuliation. By 
combining radioisotopes (or immunostaining methods) with SDS-PAGE (or isoelectric 
focusing), a mixture of proteins can be used to directly compare the specificity of certain 
enzymes. 
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Table 1. A comparison of the effectiveness of thioredoxin and PDI to glutaredoxin. 
Molecular Mass (IcDa) TRX/GRX PDI/GRX 
15 0.013 0.0012 
27 0.011 N.D. 
28 0.029 0.012 
30 (carbonic anhydrase IE) 0.0033 0.0051 
45 0.023 0.0049 
48 0.019 0.0095 
77 0.056 0.024 
88 0.033 0.017 
97 0.023 0.017 
100 0.039 0.016 
140 0.048 0.019 
The dethiolation rates of protein bands in Figure 4 were compared on a molar basis. 
The rates of dethiolation for each dethiolase were normalized for the amount of dethiolase 
used. These values were divided to give the data shown above. 
N.D., not detected, the 27 kDa protein was not dethiolated by protein disulfide isomerase. 
Figure 1. S-thiolated hepatocyte proteins 
Hepatocyte proteins were S-thiolated and isolated as described under Materials and 
Methods. The proteins were separated on the basis of their mobilities on a SDS-
polyacrylamide gel. The radioactivity associated with individual bands was visualized by 
autoradiography. 
(A) A comparison of the S-thiolated proteins by diamide and by menadione. Hepatocytes 
were incubated with either 0.5 mM diamide for 5 min or 0.2 mM menadione for 30 min to 
stimulate protein S-thiolation. The isolated proteins were separated on a 10 % SDS-
polyacrylamide gel. 
(B) S-thiolated hepatocyte proteins by 2 mM diamide for 5 min. The isolated proteins 
were separated on a 5-20 % gradient SDS-polyacrylamide gel. In order to test whether the 
radioactivity associated v^th the proteins was due to S-thiolation the mixed proteins were 
reduced with 20 mM dithiothreitol for 1 hour at 30 °C. 
(C) Relative radioactivity on individual protein bands. The relative radioactivity on each 
band was determined by scanning the autoradiogram, as described under Materials and 
Methods. 
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35 35 Figure 2. Identification of S-iabeled materials in hepatocytes, and S-iabeied thi­
ols released from the hepatocyte protein mixture 
(A) Perchloric acid (PCA)-soluble materials in hepatocytes. PCA-soluble materials were 
35 
extracted from hepatocytes incubated with Tran S-label and were separated by a HPLC 
column, as described under Materials and Methods. The HPLC fractions were counted by 
a liquid scintillation. 
35 (B) Identification of the radioactive thiols released by dithiothreitol. The S-thiolated 
hepatocyte proteins were incubated with 20 mM dithiothreitol at 30 °C for 1 hour. The 
radioactive thiols released by reduction were analyzed by the same HPLC method. 
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Figure 3. Dethiolation of hepatocyte proteins by giutaredoxin, thioredoxin, and 
protein disulfide isomerase 
• 35 The hepatocyte proteins (1 mg/ml, 14 fiM of S-thiolated proteins) were dethiolated 
with pig liver giutaredoxin (GRX) and bovine liver protein disulfide isomerase (PDI) in 
the presence of 0.3 mM glutathione. Human and E. coli thioredoxin (TRX) were 
incubated with 0.4 mM NADPH and bovine heart thioredoxin reductase (0.3 mg/ml) 
before adding the protein substrates. Aiter S min incubation, the proteins were 
precipitated by adding bovine serum albumin (6 mg/ml) and 10 % trichloroacetic acid 
(TCA). The TCA-soluble radioactivity in the supernatant released by dethiolation was 
then counted. 
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Figure 4. Specificity of glutaredoxin, thioredoxin, and protein disulfide isomerase 
for individual proteins 
The hepatocyte proteins (1 mg/ml) were dethiolated with 0.37 nM pig liver 
glutaredoxin and 25 ^M bovine liver protein disulfide isomerase in the presence of 0.3 
mM glutathione. Dethiolation by 10 fiM human recombinant thioredoxin was done in the 
presence of 0.4 mM NADPH and bovine heart thioredoxin reductase (0.3 mg/nU). After 5 
minutes, the reaction mixture was treated with an equal volume of 0.125 M Tris-Cl buffer, 
pH 6.8 containing 4 % sodium dodecyl suliate, 20 % glycerol, 0.008 % bromophenol blue, 
and 80 mM N-ethylmaleimide. The individual proteins were separated on a 5-20 % 
gradient SDS- PAGE. Dethiolation of individual proteins was determined by 
autoradiography and densitometry, as described under Materials and Methods. Pig liver 
glutaredoxin and protein disulfide isomerase dethiolated 33 % of total protein-bound 
radioactivity, and human thioredoxin dethiolated 29 %. Open bar, glutaredoxin; Hatched 
bar, thioredoxin; Closed bar, protein disulfide isomerase. 
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Figure 5. Reduction state of thioredoxin 
E. coli thioredoxin and human recombinant thioredoxin (10 ^M) were pre-incubated in 
the presence of 0.4 mM NADPH and bovine heart thioredoxin reductase (0.3 mg/ml) for 
30min at 30 °C, as in Figure 4. After incubation, an equal volume of 40 mM iodoacetic 
acid (lAA) in SO mM Tris-Cl buffer, pH 8.0 was added to block free sulfhydryb. 
Thioredoxins were focused at the lower pis when they were reduced and reacted with 
lAA. Lane 1, oxidized E. coli thioredoxin; Lane 2, E. coli thioredoxin reduced by 
thioredoxin reductase and NADPH; 
Lane 3, thioredoxin reductase alone incubated with NADPH; Lane 4, oxidized human 
thioredoxin; Lane 5, human thioredoxin reduced by thioredoxin reductase and NADPH. 
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Figure 6. Comparison of glutaredoxins and thioredoxins from different sources 
(A) Comparison of dethiolation by pig liver glutaredoxin and bovine heart glutaredoxin. 
The hepatocyte proteins (1 mg/ml) were dethiolated to a similar extent (33 %) by 0.37 
pig liver glutaredoxin or 1 fiM bovine heart glutaredoxin. Dethiolation of individual 
proteins were determined as described in Figure 4. Open bar, pig liver glutaredoxin; 
Hatched bar, bovine heart glutaredoxin. 
(B) Comparison of dethiolation by human recombinant thioredoxin and £. coli 
thioredoxin. The hepatocyte proteins (1 mg/ml) were dethiolated to a similar extent (29 
%) by 10 fiM human recombinant thioredoxin or 10 fiM E. coli thioredoxin. Dethiolation 
of individual proteins were measured as described in Figure 4. Open bar, human 
thioredoxin; Hatched bar, E. coli thioredoxin 
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Figure 7. Insulin reduction by glutaredoxin, tiiioredoxin, and protein disulfide 
isomerase 
Reduction of insulin disulfides by dithiothreitol was measured in the presence of 
glutaredoxin, thioredoxin, and protein disulfide isomerase, as described by Holmgren (34) 
and Bardwell et al. (35). The reaction mixtures contained 0.33 mM dithiothreitol, 0.13 
mM insulin, 2 mM EDTA, and a dethiolating protein, all in 0.1 M sodium phosphate 
buffer, pH 7.0. The reactions were started by adding insulin. The reduction of insulin 
disulfide was measured at 650 nm at 25 °C. hTRX, human thioredoxin; eTRX, E. coli 
thioredoxin; PDI, bovine liver protein disulfide isomerase; GRX, pig Uver glutaredoxin. 
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Figure 8. Redox equilibrium of pig liver glutaredoxin with glutathione 
Pig liver glutaredoxin (0.5 mg/ml) was incubated with GSH/GSSG mixtures in 20 mM 
fi-glycerophosphate buffer, pH 7.0, for 24 hr at 25 °C. After incubation, an equal volume 
of 40 mM iodoacetic acid in 50 mM Tris-Cl buffer, pH 8.0 was added to block fi-ee 
sulfhydryls stopping all reactions. (A) Isoelectric focusing of glutaredoxin.Oxidized and 
reduced forms of glutaredoxin were separated by isoelectric focusing and the amount of 
reduced glutaredoxin (the major band) was determined by densitometry. The GSH and 
GSSG concentrations were also measured by HPLC. The concentrations of glutathione 
were; Lane 1, 2.90 mM GSH and 0.226 mM GSSG; Lane 2, 0.965 mM GSH and 0.190 
mM GSSG; Lane 3, 0.272 mM GSH and 0.147 mM GSSG; Lane 4, 0.081 mM GSH and 
0.114 mM GSSG. 
(B) Redox state of pig liver glutaredoxin compared to [GSH]^/[GSSG]. The theoretical 
curve plotted in a solid line was drawn from equation 2 using an equilibrium constant of 
1020M'V 
R (fraction of the reduced GRX) 
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DETfflOLATION OF S-GLUTATmOLATED PROTEINS 
BY GLUTATHIONE (GSH) 
A paper to be submitted to the Journal of Biological Chemistry 
Ghe-hun Jung and James A. Thomas 
ABSTRACT 
• 35 Direct dethiolation of a mixture S-glutathiolated proteins by glutathione was studied. 
35 35 The S-glutathiolated protein mixture was isolated from S-labeled rat hepatocytes after 
stimulation with diamide. The protein mixture was treated with N-ethylmaleimide to block 
reactive sulfliydryls. It contained no thioredoxin or glutaredoxin-like activities. Dethiolation of 
individual protein bands was analyzed by combining SDS-PAGE and autoradiography. All of 
the hepatocyte proteins were dethiolated by glutathione, but the dethiolation rates of 
individual proteins varied somewhat from protein to protein. The most rapidly dethiolated 
proteins, the 4S and 140 IcDa proteins, were dethiolated 2.S times iaster than the least reactive 
proteins, the 74, 77, and 88 kDa proteins. 
Dethiolation of the mixed hepatocyte proteins was saturable with respect to the 
concentration of glutathione. The half maximal rate of dethiolation occurred at 0.16 mM 
glutathione. Dethiolation of pure S-glutathiolated phosphorylase b also showed the same satu­
ration kinetics with the half maximal rate at 0.16 mM glutathione. This confirmed the data 
with hepatocyte proteins and eliminated any potential contamination by GSH-dependent 
dethiolase such as glutaredoxin. Dethiolation rate was inhibited by denaturing agents such as 
guanidinium chloride and sodium dodecyl sul&te, and glutathione analogs, S-methyl 
glutathione and glutathione sulfonate. The saturation kinetics, inhibition by glutathione 
analogs and protein denaturants, strongly suggest that glutathione forms a noncovalent 
complex with the mixed hepatocyte S-glutathiolated proteins and with S-glutathiolated 
phosphorylase b, as a prerequisite to the reduction of the disulfides of those proteins. It is 
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suggested that the S-glutathioIation site on all these proteins contains a glutathione-binding 
site that is responsible for proper orientation of glutathione during its reduction of the protein-
glutathione mixed disulfide bonds. 
EmiODUCTION 
Glutathione is the most abundant nonprotein thiol in most cells with a concentration as 
high as 10 mM in the liver (1). It has been suggested that glutathione may be an important 
component in various cellular activities such as the synthesis of precursors of DNA (2), 
detoxification of compounds by glutathione S-transferase system (3), and the removal of 
hydrogen peroxide and organic peroxides by glutathione peroxidase (4). It has also been 
suggested that protein thiols may act as an important antioxidant system and that protein 
thiols are protected from irreversible oxidations through protein S-thiolation and dethiolation 
(S, 6). Glutathione is of central importance in those processes. 
Protein S-thiolation is the formation of mixed-disulfides between protein thiols and 
nonprotein thiols. In this process, glutathione is the major thiol forming the mixed-disulfides 
in vivo, even though other thiols such as cysteine, homocysteine, or cysteamine can also form 
mixed-desulfides. Protein S-thiolation is a dynamic process in which protein S-thiolation is 
stimulated rapidly in cells under oxidative stress and the S-thiolated proteins were in turn 
readily reduced by dethiolaton reaction (7-10). 
Dethiolation is a reverse reaction of S-thiolation (11). In the previous paper, we examined 
the role of dithiol proteins such as glutaredoxin, thioredoxin, and protein disulfide isomerase 
in dethiolation. All the dithiol proteins facilitated dethiolation of S-thiolated hepatocyte 
proteins and glutaredoxin was the most effective among those tested. It was then suggested 
that glutaredoxin probably accounted for most of the dethiolation in cells. 
Dethiolation can also occur by thiol-disulfide exchange reaction between S-thioIated 
proteins and thiols. Since the cellular concentration of glutathione is as high as 10 mM in the 
liver, direct dethiolation by glutathione through thiol-disulfide exchange reaction may be an 
important mechanism in dethiolation. In this report, we examined direct dethiolation of mixed 
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hepatocyte proteins by glutathione. The results presented here suggest that glutathione forms 
noncovalent complexes with S-thiolated proteins during dethiolation. This binding greatly 
enhances the dethiolation rate at the lower concentration of glutathione. This is the first report 
on noncovalent glutathione-binding to proteins which undergo S-thiolation and dethiolation 
under oxidative stress. 
MATERIALS AND METHODS 
Glutathione, dithiothreitol, bovine serum albumin, collagen, N-ethylmaleimide, galactose, 
and dexamethasone were purchased from Sigma chemical Co. (St. Louis, MO). Insulin 
(bovine), transferrin (human), penicillin G, streptomycin sulfate, Leibovitz's L-15 medium 
with L-glutamine were from Gibco BRL (Grand Island, NY). Collagenase was from 
Worthington biochemical Corp. (Freehold, NJ). SDS-PAGE molecular mass standards were 
35 from Bio-Rad laboratories (Richmond, CA). Trans S-label was from ICN biochemical. Inc. 
(Irvine, CA). Precasted 5-20 % gradient SDS-PAGE gels were from Jule Inc. (New Haven, 
CT). 
35 Preparation of S-glutathiolated Hepatocyte Proteins 
Sprague-Dawley male rats (200-2S0 g) (Sasco Co., Omaha, NE) were used to prepare 
hepatocytes by collagenase digestion, as described by Bonney et al. (12). Cell viability was 
greater than 90% by trypan blue exclusion. The isolated hepatocytes were diluted to 0.5x10^ 
cells/ml in Leibovitz's L-IS medium, pH 7.6, supplemented with 18 mM Hepes, 0.2% bovine 
serum albumin, 5 ng/ml insulin/transferrin, 1 ^M dexamethasone, S mg/ml galactose, SO 
Units/ml penicillin G, and SO fig/ml streptomycin sulfate and plated on collagen-coated dishes. 
The hepatocytes were incubated at 37 °C for 48 hours before [^^S]-labeling. 
Cells were incubated in L-IS medium containing IS ^g/ml cycloheximide for 30 minutes 
35 prior to labeling. Cycloheximide prevented protein synthesis during S-labeling. 
Cycloheximide- treated cells were then incubated for 4 hours with serum-free CMRL-141S 
medium containing 40 ^M methionine, 10 ^M cystine, and 15 ^g/ml cycloheximide with 
3x10 dpm/^mole. The low concentration of methionine and cystine in CMRL-141S medium 
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was convenient for labeling the cells with a higher specific activity. The specific activity of 
glutathione in cells was analyzed by HPLC as described by Fariss and Reed (13) and modified 
35 by Chai et al. (8). The acid-soluble materials in S-labeled hepatocytes were separated by a 
HPLC column and fractions were counted by a liquid scintillation counter. 
35 S-labeled hepatocytes were treated with 2 mM diamide for 5 minutes to S-thiolate 
proteins. After incubation, the medium was removed and cells were rinsed twice with cold 
phosphate buffered saline. Cells were extracted within a minute by scraping cells in 20 mM 
Hepes pH 7.4 buffer containing 5 mM EDTA, S mM EGTA and SO mM N-ethylmaleimide. 
N-ethylmaleimide was prepared fresh for each experiment. The extract was centrifuged at 
10,000 X g for 30 minutes to obtain a particulate-free cell extract. The supernatant was 
dialyzed to remove low molecular mass radioactivity using 12-14 IcDa molecular mass cut-off 
dialysis tubing. 
Glutaredoxin and thioredoxin activity in the extract were measured as described by Thomas 
et al. (14), using [ H]-phosphoryIase b as a substrate. Neither glutaredoxin nor thioredoxin 
activity was detected in the extract. The protein concentration was determined as described by 
Lowry et al. (IS) using bovine serum albumin as standard. 
Determination of the thiol anion concentrations 
The ultraviolet absorption was utilized to determine the concentrations of thiol anions at 
pH 7.0 (16). Ionization of the glutathione -SH group gives a unique absorption at 232 nm 
with a molar extinction coefficient of 5690 (M'^cm'^) and cysteine at 236 nm with a molar 
extinction coefficient of 52S0 (M'^cm'^). The extent of ionization of glutathione and cysteine 
was 0.85 % and 3.44 %, respectively. 
Assay of dethiolation reaction 
In order to measure the overall dethiolation rate, either protein-bound radioactivity or the 
released radioactivity from proteins was determined. In the former case, aliquots of the 
reaction mixture were spotted on filter paper squares (17). The TCA-precipitable radioactivity 
bound to the paper was measured by liquid scintillation. In the latter case, the hepatocyte 
proteins, after reaction, were precipitated with 10 % trichloroacetic acid (TCA). The TCA-
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soluble radioactivity in the supernatant, which represents the extent of dethiolation, was 
counted by liquid scintillation (14). 
In order to measure dethiolation of individual protein bands, the reaction was stopped by 
adding an equal volume of 0.125 M Tris-Cl buffer, pH 6.8 containing 4 % sodium dodecyl 
sulfate, 20 % glycerol, 0.008 % bromophenol blue, and 80 mM N-ethylmaleimide. N-
ethylmaleimide stopped the reaction and blocked free sulfhydryls. Proteins were separated 
by 5-20 % gradient SDS-PAGE. The radioactivity associated with individual bands was 
visualized by autoradiography, and quantitated by densitometry. 
RESULTS 
35 S-thiolated hepatocyte proteinSi 
In order to study dethiolation, S-thiolated proteins were prepared from hepatocytes 
stimulated with diamide. The mixture of proteins isolated from diamide-treated hepatocytes 
were characterized by separation on a SDS-PAGE gel [Figure 1 (A)]. The relative 
radioactivity on each protein band was determined by combining autoradiography and 
densitometry [Figure 1 (B)]. The 30 IcDa protein, which has been identified as carbonic 
anhydrase m (18), was the most abundant S-thiolated protein, containing 20 % of the total 
protein-bound radioactivity. All the protein bands were completely dethiolated by 
dithiothreitol, indicating that the radioactivity on proteins was derived from bound 
35 S-glutathione not from the protein itself The protein mixture contained less than 0.2 % 
TCA-soluble radioactivity when no reductant was added. 
The radioactive materials incorporated into S-thiolated proteins were released by 
dithiothreitol, and identified by a HPLC method (8,13). More than 84 % of protein-bound 
radioactivity was identified as glutathione. Therefore, the mixed hepatocyte proteins contained 
35 
mainly [ S]-glutathione (i.e. S-glutathiolated), with fourteen nmole of glutathione bound to 
one mg hepatocyte proteins. The extent of S-thiolation represents approximately 30 percent 
of the readily S-thiolated sites in hepatocyte proteins. N-ethylmaleimide (NEM) was added 
during isolation, so all the reactive sulfhydryls were either S-glutathiolated or NEM-modified. 
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NADPH-dependent and GSH-dependent dethiolases (i. e., reductases for protein mixed-
disulfides) greatly enhanced dethiolation of hepatocyte proteins (19). Therefore, any 
contaminating dethiolase activities in the protein preparation could interfere the analysis of the 
dethiolation by glutathione. Although the dethiolase activities has been measured utilizing S-
[ HJglutathiolated phosphorylase b (14), it was not practical to directly measure dethiolase 
activities in the hepatocyte protein mixture because the much higher radioactivity on 
35 [ S]-labeled hepatocyte proteins interfered the dethiolase assay. In order to measure 
dethiolase activities in the protein preparation, a S-glutathiolated protein mixture was 
35 prepared from the cells with no [ S] label. Neither glutaredoxin nor thioredoxin activity was 
detected in the mixture of S-glutathiolated proteins, suggesting that the mixture of 
35 [ S]-labeled hepatocyte proteins used for this paper may also be dethiolase-free. The 
dethiolases may be inactivated by N-ethylmaleimide during cell lysis if they were in the 
reduced state, and residual activity may have been eliminated during the extensive dialysis 
with a membrane that does not completely retain 12 kDa proteins. 
Dethiolation of the hepatocyte proteins by various thiols 
The time dependent dethiolation of hepatocyte proteins by reduced glutathione (GSH), 
cysteine, and dithiothreitol is shown in Figure 2. In the absence of any thiol, there was no 
detectable loss of the radioactivity on proteins. This indicated that the decrease of 
radioactivity by the thiols was solely due to dethiolation (i.e., reduction of mixed-disulfides). 
The reduction was not a Ist-order reaction. This non-lst order kinetics may partly be a result 
of various dethiolation rates of individual proteins consisting the mixture. The redox states of 
glutathione were determined by HPLC before and after dethiolation. After 80 minute 
incubation, the concentrations of reduced glutathione (GSH) in the reaction mixtures initially 
containing 5,1, and 0.2 mM GSH were 4.9, 0.90, and 0.14 mM, respectively. Therefore, 
dethiolation by 0.2 mM GSH after 80 min was probably slower as a result of the decrease 
GSH and the decreased GSH may also contribute to the non-lst order dethiolation. 
Dethiolation by 1 mM cysteine and S mM dithiothreitol also showed similar non-lst order 
kinetics. One mM cysteine was as effective as one mM glutathione, and five mM dithiothreitol 
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was considerably more effective than the same concentration of glutathione. 
In Figure 2, cysteine and glutathione gives equal rates of dethiolation at 1 mM. Since the 
piCa of the glutathione sulfhydryl has been reported to be 9.2 and that of cysteine to be 8.48 
(15, 20), the concentration of cysteine thiol anion at pH 7.0 should be 5 times higher than 
glutathione if they follow simple dissociation of mono-ionic species. The thiolate ion 
concentrations in 1 mM glutathione and 1 mM cysteine at pH 7 were determined to be 8.5 
^M and 34.4 ^M, respectively, as described under Materials and Methods. Thus, the 
concentration of thiolate ion, the reactive species for dethiolation reaction, of 1 mM cysteine 
at pH 7.0 is 4 times higher than that of 1 mM glutathione and yet each gave an equal rate of 
dethiolation. 
Dethiolation by glutathione shows saturation kinetics 
The dethiolation rate is not directly proportional to the amount of glutathione, and Figure 
3 shows that it is saturable with respect to the glutathione. The dethiolation rates followed 
Michaelis-Menten kinetics in which the half maximal rate of dethiolation occurred at 1.4 ^M 
of glutathione thiolate, equivalent to 0.16 mM GSH. These saturation kinetics suggest that 
glutathione forms a noncovalent complex with S-glutathioIated proteins during dethiolation. 
Dethiolation by cysteine did not show saturation at this concentration. 
Since the dethiolation rate of each protein in the mixture could be different, the relatively 
fast reaction at the lower concentration of glutathione might represent the dethiolation of the 
fast reacting proteins that were specific for glutathione. The slower increase in dethiolation 
rates at higher concentrations of glutathione might result from the dethiolation of the slower 
reacting proteins. 
In order to examine this possibility, the dethiolation of pure, [^H]S-glutathioIated 
phosphorylase b was examined, as shown in Figure 4. [ H]S-glutathiolated phosphorylase b 
was prepared by diamide reaction as described by Thomas et al. (14). The dethiolation rate 
was again saturable with respect to glutathione and the half maximal dethiolation occurred at 
1.4 (iM of glutathione thiolate. This suggested that glutathione formed a noncovalent complex 
with S-glutathiolated phosphorylase b during dethiolation and that the saturation kinetics of 
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the hepatocyte protein mixture were also due to noncovalent GSH-binding to the proteins, 
analogous to enzyme-substrate complexes. 
Dethiolation of individual proteins by glutathione 
In order to examine specificity of dethiolation for individual proteins, the mixture of 
hepatocyte proteins was separated by gel electrophoresis and the extent of dethiolation by 
glutathione was determined by autoradiography and densitometry. Figure 5 shows the extent 
of dethiolation of the 12 major proteins in the mixture by 0.5 mM glutathione (5 A) and by 5 
mM glutathione (5B). Overall, the relative dethiolation of individual proteins by 0.5 mM GSH 
was similar to 5 mM GSH. The 45 and 170 kDa proteins were dethiolated most rapidly, 
approximately 2.5 times faster than the 74, 77, and 88 kDa proteins. Inhibition by 
glutathione analogs and denaturing agents 
Figure 6 shows that both 4 M guanidinium chloride and 0.1 % sodium dodecyl sul&te 
decrease the rate of dethiolation. This decreased dethiolation may result from the loss of 
glutathione interaction with the S-glutathiolation site in the presence of denaturing agents. If 
glutathione binds to the site during dethiolation, glutathione analogs may compete for the 
same binding sites. Table 1 shows that either glutathione sulfonate or S-methyl glutathione 
inhibits the dethiolation, suggesting again that glutathione binds to proteins during 
dethiolation. 
DISCUSSION 
The experiments presented in this report suggest that glutathione is capable of forming a 
noncovalent complex with S-glutathiolated proteins, and this binding increases the 
effectiveness of low glutathione concentrations as a dethiolating agent. The dethiolation of 
both mixed hepatocyte proteins and pure phosphorylase b comply with the Michaelis-Menten 
model with the half maximal rate at 0.16 mM glutathione. 
Since glutathione is such an abundant thiol in most cells, it has been suggested that thiol-
disulfide exchange with reduced glutathione may be important for dethiolation. On the 
contrary, from the following observations, it has also been suggested that glutathione itself 
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may not be an important dethiolating agent (9, 21, 22). First, dethiolation is greatly i&cilitated 
by dithiol proteins, especially by glutaredoxin. In the previous paper, it was suggested that 
glutaredoxin might account for most of the dethiolation in cells by the reactivity and the 
cellular concentration of glutaredoxin. Second, glutathione showed a relatively lower 
reactivity on a molar basis and the low activity is probably due to the higher pKa of 
glutathione. 
Noncovalent glutathione-binding to several glutathione-utilizing enzymes such as 
glutathione S-transferase (23,24), glyoxalase I (25), glutathione peroxidase (26), and 
glutathione reductase (27) has been described in detail. Glutatathione-binding to the 
glutathione-utilizing enzymes may not be surprising because enzyme catalysis includes 
enzyme-substrate complex. On the other hand, there have been reports of noncovalent 
interaction of glutathione with hemoglobin at the S-thiolation site (28). A putative 
glutathione-binding site in CdZn-metallothionein has also been suggested (29). Since 
hemoglobin and metallothionein has not been related with glutathione metabolism, the role of 
glutathione binding to those proteins is not understood. 
Glutathione-binding to the S-glutathiolated proteins suggests that S-glutathiolated proteins 
may contain a GSH-binding site even in the reduced state. In addition, since the hepatocyte 
protein thiols available for S- thiolation has been estimated to be SO nmol/mg protein, 
approximately 10 mM thiols in the liver, the concentration of glutathione-binding sites may 
also be as high as 10 mM in cells. 
Reactive oxygen species (ROS)-initiated S-thiolation has been suggested as a major S-
thiolation mechanism in which protein thiols are activated by ROS, and in turn a reduced 
glutathione reacts with the "activated" protein thiols to form a disulfide bond. The 
experiments presented in this report suggest that GSH-binding sites may be closely associated 
with the reactive sulfliydryls that participate in S-glutathiolation. That is, the binding sites 
provide glutathione ready for S-thiolation under oxidative stress. 
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Table 1. Inhibition of dethiolation by glutathione sulfonate and S-methyl glutathione 
dethiolation (%) 
0.14 mM GSH alone 8.8 ± 0.4 
+ glutathione sulfonate (0.6 mM) 6.9 ±0.4 
+ glutathione sulfonate (1.2 mM) 5.4 ±0.5 
+ S-methyl glutathione (0.6 mM) 6.8 ±0.4 
S-glutathiolated hepatocyte proteins were dethiolated with 0.14 mM GSH in 20 mM 6-
glycerophophate buffer, pH 7.0, at 30 °C Aiter5 min incubation,-the protein mixture was 
precipitated by adding bovine serum albumin (6 mg/ml) and 10 % trichloroacetic acid. The 
radioactivity in the supernatant was counted by a liquid scintillation. The same experiments 
were repeated in the presence of of glutathione sulfonate and S-methyl glutathione. 
Figure 1. S-glutathiolated hepatocyte proteins 
Hepatocyte proteins were S-glutathiolated and isolated, as described under Materials 
and Methods. The proteins were separated on a SDS-polyacrylamide gel and the 
radioactivity associated with individual bands was visualized by autoradiography. 
35 (A) S-glutathiolated proteins from hepatocytes treated with by 2 mM diamide for S min. 
The proteins were separated on a 5-20 % gradient SDS-polyacrylamide gel. The 
radioactivity associated with the proteins was released by reduction as shown in the right 
lane (20 mM dithiothreitol for 1 hour at 30 °C). Dithiothreitol did not cause any detectable 
change in the protein bands. (B) Fraction of the total radioactivity associated with 
separate protein bands were determined by scanning the autoradiogram. 
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Figure 2. Dethiolation of hepatocyte proteins by glutathione, cysteine, and 
dithiothreitol 
Hepatocyte proteins (2 mg/ml) were dethiolated with various concentrations of 
glutathione in 20 mM B-glycerophosphate buffer, pH 7.0, at 30 °C. During the reactions, 
aliquots of the reaction mixture were spotted on squares of filter paper, and the radioac­
tivity precipitated on the papers by 10 % trichloroacetic acid was measured by liquid 
scintillation counting. 
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Figure 3. Glutathione concentration dependence of dethiolation 
The ^^S-thiolated proteins were dethiolated with various concentrations of glutathione 
and cysteine for 5 min at 30 °C in 20 mM B-glycerophophate buflfer, pH 7.0. The proteins 
in the reaction mixture were then precipitated with 10 % trichloroacetic acid (TCA). The 
TCA-soluble radioactivity in the supernatant, released by dethiolation, was counted. 
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Figure 4. Dethiolation of [^HJS-glutathiolated phosphorylase b 
Dethiolation of [^]S-thiolated phosphorylase b (0.3 ^M) was measured, as described 
in the legend of Figure 3. After incubation, phosphorylase b was precipitated with 10 % 
trichloroacetic acid (TCA) and The TCA-soluble radioactivity in the supernatant was 
counted. The small graph inserted inside the figure is a double-reciprocal plot. 
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Figure 5. Dethiolation of individual proteins by glutathione 
The protein mixture (2 mg/ml) were incubated with O S and 5 niM GSH under the 
condition described in the legend of Figure 2. After 10 min incubation, dethiolation 
reaction was stopped by adding an equal volume of 0.125 M Tris-Cl buffer, pH 6.8 
containing 4 % sodium dodecyl suliate, 20 % glycerol, 0.008 % bromophenol blue, and 80 
mM N-ethylmaleimide. N-ethylmaleimide stops the reaction and blocks free sulfhydryls. 
Proteins were separated by a 5-20 % gradient SDS-PAGE. The radioactivity associated 
with individual bands was quantitated by autoradiography and densitometry. (A) The 
extent of dethiolation by 0.5 mM glutathione. (B) Dethiolation by S mM glutathione 
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Figure 6. Dethiolation of hepatocyte proteins in the presence of guanidinium 
chloride and sodium dodecyl sulfate 
The protein mixture (2 mg/ml) were incubated at 30 with 0.5 mM GSH in the 
presence of 0.1 % sodium dodecyl sul&te and 4 M guanidinium chloride. During the 
reactions, aliquots of the reaction mixture were spotted on filter paper squares and the 
radioactivity precipitated on the papers by trichloroacetic acid was measured, as described 
in the legend in Figure 2. 
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SUMMARY AND CONCLUSION 
35 The experiments described in this dissertation explored dethiolation of S-glutathiolated 
hepatocyte proteins. In the first paper, the redox-active dithiol proteins, glutaredoxin, 
thioredoxin, and protein disulfide isomerase, were examined as dethiolases (i.e., reductases for 
protein mixed-disulfides) by studying their specificities in dethiolation. Non-enzymatic 
dethiolation by glutathione (GSI^ was studied in the second paper. These experiments gave a 
clue to understand the role of dethiolation in response to oxidative stress, and the mechanism 
of dethiolation to maintain the protein thiols in the reduced state in cells. 
In order to study the specificities of those redox-active dithiol proteins, a mixture of 
35 S-glutathiolated hepatocyte proteins was used. Each of the dithiol proteins greatly 
enhanced the dethiolation rate and could completely dethiolate all of the S-glutathiolated 
proteins. When the dethiolation rates of individual proteins were compared, glutaredoxin was 
the most effective. For example, carbonic anhydrase m, a major S-thiolated protein in 
hepatocytes (22), was dethiolated 300 times &ster by glutaredoxin than thioredoxin, and 200 
times faster than by protein disulfide isomerase. Glutaredoxin fi-om pig liver and bovine heart 
showed a similar specificity. Dethiolation rates of individual hepatocyte proteins by 
glutaredoxin varied in minor ways fi-om protein to protein. For example, the 15, 30, and 48 
kDa proteins were quickly dethiolated by glutaredoxin, and the 27, 28, and 77 kDa proteins 
were dethiolated more slowly. 
Although glutaredoxin was the most effective enzyme for dethiolation, it did not catalyze 
the reduction of insulin disulfides. On the other hand, protein disulfide isomerase and 
thioredoxin were effective with insulin disulfides. This indicates that glutaredoxin may be 
specific for S-glutathiolated proteins. The cellular concentration of glutaredoxin and the 
reactivity of purified pig liver glutaredoxin strongly suggest that glutaredoxin probably 
accounts for most of the dethiolation in cells. 
The standard redox potential of pig liver glutaredoxin was - 0.16 V at pH 7.0 and 25 °C, 
surprisingly higher than that (- 0.26 V) of E. coli thioredoxin (41). This high redox potential 
indicates that glutaredoxin itself is a weaker reductant than thioredoxin. Glutathione-binding 
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at the active sites of glutaredoxin is suggested as a structural factor for the effective 
dethiolation. The high redox potential of glutaredoxin also implies that glutaredoxin may be in 
the fully reduced state in the liver under the reported concentrations of GSH and GSSG (10 
mM GSH, 30 ^M GSSG), and may be fairly active even under the highly oxidized conditions. 
Since the cellular glutathione concentration may be as high as 10 mM, thiol-disulfide 
reaction of S-gluatathiolated proteins by glutathione (GSH) may be an important dethiolation 
35 
mechanism. Therefore, the nonenzymatic dethiolation of S-glutathioIated hepatocyte 
proteins by glutathione alone was also studied in this report. All of the S-thiolated proteins 
were dethiolated by glutathione. The dethiolation rates of individual proteins varied only in 
minor ways from protein to protein. 
The dethiolation of the S-glutathiolated proteins was saturable with respect to the 
concentration of glutathione. The dethiolation rates follow the Michaelis-Menten kinetics with 
the half maximal rate at 0.16 mM glutathione, suggesting that dethiolation of S-glutathiolated 
proteins by reduced glutathione (GSH) may occur at the maximal rate in cells. This implies 
that thiol-disulfide exchange reaction by glutathione may also be significant in dethiolation. 
The dethiolation rate decreased in the presence of denaturing agents such as guanidinium 
chloride and sodium dodecylsulfate. The glutathione analogs, S-methyl glutathione and 
glutathionesulfonate, also inhibited the dethiolation by glutathione. The saturation kinetics, 
and inhibition by glutathione analogs and denaturants, strongly suggested that glutathione 
forms a noncovalent complex with S-glutathioIated proteins during dethiolation. 
The noncovalent glutathione-binding to the S-glutathiolated proteins suggests that those 
proteins may bind GSH even in the reduced state, unless S-glutathioIation induces additional 
GSH-binding to the proteins. It is suggested in this report that those GSH-binding sites in the 
reduced proteins may be filled with glutathione (GSH), and thereby the proteins are ready for 
S-thiolation under oxidative stress. 
The experiments presented in this dissertation suggests that glutaredoxin may be the major 
dethiolases in most cells, and nonenzymatic dethiolation by glutathione may also be a 
significant mechanism under certain conditions. The glutathione-binding site on glutaredoxin 
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may be a structural factor for the effective dethiolation by glutaredoxin. Many proteins with 
reactive sulfliydryls may bind glutathione (GSH) noncovalently. The bound glutathione then 
forms a mixed-disulfide with the "reactive" protein thiols near the binding site under oxidative 
stress. 
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